Clene Inc. Profile Avatar - Palmy Investing

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, incl…

Biotechnology
US, Salt Lake City [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CLNN's Analysis
CIK: 1822791 CUSIP: 185634102 ISIN: US1856341029 LEI: - UEI: -
Secondary Listings
CLNN has no secondary listings inside our databases.